Tilray Brands, Inc. to Announce Third Quarter Fiscal 2025 Financial Results on April 8, 2025

3/27/25 4:30:00 PM ET

Medicinal Chemicals and Botanical Products

Health Care

Get the next $TLRY alert in real time by email

NEW YORK and LEAMINGTON, Ontario, March 27, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, today announced that the Company will release financial results for its third quarter fiscal 2025 ended February 28, 2025 before financial markets open on April 8, 2025.

Live Conference Call and Audio Webcast

Tilray will hold a live conference call, which will be webcast, to discuss these results at 8:30 a.m. Eastern Time. The webcast can be accessed in the Investors section of Tilray's website at www.Tilray.com.

About Tilray Brands

Tilray Brands, Inc. ("Tilray") (NASDAQ:TLRY, TSX:TLRY), is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. Tilray's mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy and create memorable experiences. Tilray's unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.

For more information on how we are elevating lives through moments of connection, visit Tilray.com and follow @Tilray on all social platforms.

Media Contact: [email protected]

Investor Contact: [email protected]

Get the next $TLRY alert in real time by email

Recent Analyst Ratings for

$TLRY

Date	Price Target	Rating	Analyst
4/5/2024	$2.25 → $2.75	Neutral	Alliance Global Partners
11/2/2022	$3.90	Mkt Perform	Bernstein
7/29/2022	$3.00	Hold → Sell	The Benchmark Company
3/4/2022	$9.00	Hold → Buy	Canaccord Genuity
1/11/2022	$7.40 → $6.90	Neutral	Cantor Fitzgerald
1/7/2022	$11.80 → $7.40	Neutral	Cantor Fitzgerald
11/18/2021	$10.00	Underweight	Barclays
11/1/2021	$18.00 → $11.80	Overweight → Neutral	Cantor Fitzgerald

More analyst ratings

Tilray Brands, Inc. to Announce Third Quarter Fiscal 2025 Financial Results on April 8, 2025

Chat with this insight

Recent Analyst Ratings for
$TLRY

$TLRY
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

President and CEO Simon Irwin D exercised 1,178,109 shares at a strike of $0.41 and covered exercise/tax liability with 647,960 shares, increasing direct ownership by 16% to 3,776,633 units (SEC Form 4)

Chief Financial Officer Merton Carl A exercised 174,477 shares at a strike of $0.41 and covered exercise/tax liability with 95,963 shares, increasing direct ownership by 11% to 764,569 units (SEC Form 4)

Chief Strategy Officer Faltischek Denise M exercised 249,353 shares at a strike of $0.41 and covered exercise/tax liability with 127,171 shares, increasing direct ownership by 23% to 657,875 units (SEC Form 4)

$TLRY
SEC Filings

Tilray Brands Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities

Tilray Brands Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

SEC Form DEFA14A filed by Tilray Brands Inc.

$TLRY
Press Releases

Fastest customizable press release news feed in the world

Montauk Brewing Celebrates 13 Years of Brewing with Faherty Collaboration and Beach Clean Up with the Surfrider Foundation

Tilray Medical Publishes Pioneering Research on the Pharmacokinetics of THC and CBD Formulations

Tilray Medical Receives Italy's First Authorization from the Ministry of Health to Distribute Medical Cannabis Flower for Therapeutic Use

$TLRY
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Alliance Global Partners reiterated coverage on Tilray with a new price target

Bernstein initiated coverage on Tilray with a new price target

Tilray downgraded by The Benchmark Company with a new price target

$TLRY
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Chief Financial Officer Merton Carl A bought $35,360 worth of shares (26,000 units at $1.36) (SEC Form 4)

Faltischek Denise M bought $20,500 worth of shares (10,000 units at $2.05), increasing direct ownership by 4% to 293,269 units (SEC Form 4)

Gendel Mitchell bought $14,256 worth of shares (7,200 units at $1.98), increasing direct ownership by 4% to 195,796 units (SEC Form 4)

$TLRY
Financials

Live finance-specific insights

Tilray Brands Reports Q3 Fiscal 2025 Financial Results